Unknown

Dataset Information

0

Lipoprotein receptor-related protein 6 is required for parathyroid hormone-induced Sost suppression.


ABSTRACT: Parathyroid hormone (PTH) suppresses the expression of the bone formation inhibitor sclerostin (Sost) in osteocytes by inducing nuclear accumulation of histone deacetylases (HDACs) to inhibit the myocyte enhancer factor 2 (MEF2)-dependent Sost bone enhancer. Previous studies revealed that lipoprotein receptor-related protein 6 (LRP6) mediates the intracellular signaling activation and the anabolic bone effect of PTH. Here, we investigated whether LRP6 mediates the inhibitory effect of PTH on Sost using an osteoblast-specific Lrp6-knockout (LRP6-KO) mouse model. An increased level of Sost mRNA expression was detected in femur tissue from LRP6-KO mice, compared to wild-type littermates. The number of osteocytes expressing sclerostin protein was also increased in bone tissue of LRP6-KO littermates, indicating a negative regulatory role of LRP6 on Sost/sclerostin. In wild-type littermates, intermittent PTH treatment significantly suppressed Sost mRNA expression in bone and the number of sclerostin(+) osteocytes, while the effect of PTH was much less significant in LRP6-KO mice. Additionally, PTH-induced downregulation of MEF2C and 2D, as well as HDAC changes in osteocytes, were abrogated in LRP6-KO mice. These data indicate that LRP6 is required for PTH suppression of Sost expression.

SUBMITTER: Li C 

PROVIDER: S-EPMC4592361 | biostudies-literature | 2016 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Lipoprotein receptor-related protein 6 is required for parathyroid hormone-induced Sost suppression.

Li Changjun C   Wang Weishan W   Xie Liang L   Luo Xianghang X   Cao Xu X   Wan Mei M  

Annals of the New York Academy of Sciences 20150402


Parathyroid hormone (PTH) suppresses the expression of the bone formation inhibitor sclerostin (Sost) in osteocytes by inducing nuclear accumulation of histone deacetylases (HDACs) to inhibit the myocyte enhancer factor 2 (MEF2)-dependent Sost bone enhancer. Previous studies revealed that lipoprotein receptor-related protein 6 (LRP6) mediates the intracellular signaling activation and the anabolic bone effect of PTH. Here, we investigated whether LRP6 mediates the inhibitory effect of PTH on Sos  ...[more]

Similar Datasets

| S-EPMC3017151 | biostudies-literature
| S-EPMC10093484 | biostudies-literature
| S-EPMC3153379 | biostudies-literature
| S-EPMC199196 | biostudies-literature
| S-EPMC2788887 | biostudies-literature
2023-10-11 | GSE244861 | GEO
| S-EPMC2884564 | biostudies-literature
| S-EPMC5790322 | biostudies-literature
| S-EPMC3874264 | biostudies-other
| S-EPMC43929 | biostudies-other